Iqvia to offer euro-denominated notes due 2028

By Rebecca Melvin

New York, June 9 – Iqvia Holdings Inc. announced that its subsidiary Iqvia Inc. plans to price an offering of euro-denominated senior notes due 2028 (Ba3/BB) for which the proceeds will be used to repurchase notes, according to a company news release on Tuesday.

The company also announced a notice of redemption of its outstanding 3½% notes due 2024.

The size of the new notes issue will be the equivalent of $800 million.

The proceeds from the new notes will be used to redeem all of the 2024 notes and to repay a portion of the existing borrowings under the issuer’s revolving credit facility.

The provider of health information technologies and clinical research is based in Durham, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.